ARS Pharmaceuticals, Inc. SPRY Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s other operating expenses?
- ARS Pharmaceuticals, Inc. (SPRY) reported other operating expenses of $82.83M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- ARS Pharmaceuticals, Inc.'s other operating expenses increased by 83.4% year-over-year, from $45.15M to $82.83M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s other operating expenses?
- Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s other operating expenses has grown at a 92.7% compound annual growth rate (CAGR), from $36.83M to $263.73M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.